Biotech & Health Tech
Bourla expects no changes to MFN deals after midterms
Pfizer CEO Albert Bourla said he doesn't expect likely Democratic gains in Congress to affect the pricing deals made between drug companies and the Trump White House. “I don't think that many things can move ...
Pfizer CEO Albert Bourla said he doesn't expect likely Democratic gains in Congress to affect the pricing deals made between drug companies and the Trump White House. “I don't think that many things can move ...
This is a summary of the story. Read the full article at Endpoints News (Biopharma) ↗